Cytosurge
Biotechnology ResearchZurich, Switzerland11-50 Employees
Cytosurge is a biotechnology research company based in Glattbrugg, Zurich, Switzerland, operating in the field of single-cell biology. Its core offering centers on a proprietary platform that enables physical access to the same living cell over time, allowing researchers to perform non-destructive sampling, perturbation, and profiling of individual cells to study dynamics and causal relationships. The company emphasizes longitudinal, Same-Cell analysis and mechanobiology measurements, supporting researchers in understanding how baseline cellular states influence future behavior and in assessing mechanical properties at the single-cell level. Its service offerings also include CellEDIT, a CRISPR-based cell line engineering service that can execute precise edits without viral delivery, expanding capabilities for genome manipulation in difficult-to-transfect cells. A notable recent development is a collaboration announced in late 2025 to integrate Cytosurge’s FluidFM OMNIUM platform with Lexogen’s RNA library preparation workflow, expanding the scope of minimally invasive cytoplasmic sampling and downstream sequencing.
1-888-653-2347 
support@leadiq.com 
